Sanofi Financial Statements From 2010 to 2024
| SNYN Stock | MXN 964.00 6.00 0.63% |
Check Sanofi financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sanofi's main balance sheet or income statement drivers, such as , as well as many indicators such as . Sanofi financial statements analysis is a perfect complement when working with Sanofi Valuation or Volatility modules.
Sanofi |
Sanofi Company Return On Equity Analysis
Sanofi's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Sanofi Return On Equity | 0.0959 |
Most of Sanofi's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sanofi is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Sanofi has a Return On Equity of 0.0959. This is 100.4% lower than that of the Healthcare sector and 95.54% lower than that of the Drug Manufacturers - Major industry. The return on equity for all Mexico stocks is 130.94% lower than that of the firm.
Sanofi Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sanofi's current stock value. Our valuation model uses many indicators to compare Sanofi value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sanofi competition to find correlations between indicators driving Sanofi's intrinsic value. More Info.Sanofi is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.63 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Sanofi is roughly 1.58 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sanofi by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sanofi's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Sanofi Financial Statements
Sanofi investors use historical fundamental indicators, such as Sanofi's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Sanofi. Please read more on our technical analysis and fundamental analysis pages.
It offers Cerezyme and Cerdelga for Gaucher, Myozyme and Lumizyme for Pompe, Fabrazyme for Fabry, and Aldurazyme for mucopolysaccharidosis Type 1 and Aubagio, an immunomodulatory and Lemtrada, a monoclonal antibody for multiple sclerosis. Sanofi was founded in 1973 and is headquartered in Paris, France. SANOFI is traded on Mexico Stock Exchange in Mexico.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Sanofi Stock Analysis
When running Sanofi's price analysis, check to measure Sanofi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi is operating at the current time. Most of Sanofi's value examination focuses on studying past and present price action to predict the probability of Sanofi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi's price. Additionally, you may evaluate how the addition of Sanofi to your portfolios can decrease your overall portfolio volatility.